已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis.

医学 内科学 相对风险 心房颤动 心力衰竭 糖尿病 安慰剂 随机对照试验 冲程(发动机) 荟萃分析 心脏病学
作者
Hang Long Li,Gregory Y.H. Lip,Qi Feng,Yue Fei,Yi Kei Tse,Mei zhen Wu,Qing Wen Ren,Hung-Fat Tse,Bernard M.Y. Cheung,Kai-Hang Yiu
出处
期刊:Cardiovascular Diabetology [BioMed Central]
被引量:37
标识
DOI:10.1186/s12933-021-01293-8
摘要

Cardiac arrhythmias are associated with poorer outcomes in patients with heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD). Previous studies have shown inconsistent conclusions regarding the association between sodium-glucose cotransporter 2 inhibitors (SGLT2i) and the risk of developing arrhythmias. This study aims to investigate the association of SGLT2i treatment with arrhythmia outcomes in clinical trials of patients with HF, DM, or CKD.MEDLINE, EMBASE, and ClinicalTrials.gov were searched from inception up to 27 August 2020. Randomized controlled trials that randomized patients with DM, CKD, or HF to SGLT2i or placebo were included. The outcomes of interest include atrial fibrillation (AF), embolic stroke, atrial flutter (AFL), AF/AFL, ventricular tachycardia (VT), and cardiac arrest. Relative risks (RRs) and 95% confidence intervals (CI) were pooled using a random-effects model.Out of 4,532 citations, 22 trials with altogether 52,115 patients were included (mean age 63.2 years; 33,747 [64.8%] of participants were men). SGLT2i were associated with a lower risk of AF (RR 0.82, 95% CI 0.70-0.96), embolic stroke (RR 0.32, 95% CI 0.12-0.85), AF/AFL (RR 0.82, 95% CI 0.71-0.95), and VT (RR 0.73, 95% CI 0.53-0.99), while the risk reductions in AFL (RR 0.83, 95% CI 0.58-1.17) and cardiac arrest (RR 0.83, 95% CI 0.61-1.14) did not reach statistical significance. The associations appeared to be consistent across different baseline conditions (DM vs CKD vs HF; atherosclerotic cardiovascular disease [ASCVD] vs no ASCVD) and the SGLT2i used.SGLT2i reduced the risk of cardiac arrhythmias. Our study provides further evidence for recommending the use of SGLT2i in patients with DM, CKD, and HF. Further research is needed to fully elucidate the mechanism by which SGLT2i protect against arrhythmias.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NexusExplorer应助人间烟火采纳,获得10
1秒前
c2完成签到,获得积分10
3秒前
一枚小医生怎么办完成签到,获得积分10
4秒前
4秒前
6秒前
c2发布了新的文献求助10
6秒前
江上游完成签到 ,获得积分10
7秒前
8秒前
8秒前
苏苏弋完成签到 ,获得积分10
10秒前
jovrtic完成签到,获得积分10
10秒前
澈澈发布了新的文献求助10
11秒前
11秒前
小马甲应助hnu采纳,获得10
11秒前
阿白完成签到,获得积分10
12秒前
Hairee发布了新的文献求助10
12秒前
章浩泽完成签到 ,获得积分10
13秒前
上上发布了新的文献求助10
13秒前
tongluobing完成签到,获得积分10
14秒前
哈哈完成签到 ,获得积分10
17秒前
情怀应助Hairee采纳,获得10
18秒前
斯文败类应助科研通管家采纳,获得10
18秒前
Owen应助科研通管家采纳,获得10
18秒前
18秒前
18秒前
idiom完成签到 ,获得积分10
19秒前
20秒前
LK完成签到,获得积分10
21秒前
24秒前
动人的阁发布了新的文献求助10
25秒前
David完成签到,获得积分10
29秒前
大力出奇迹完成签到,获得积分10
29秒前
30秒前
温水完成签到 ,获得积分10
30秒前
31秒前
31秒前
lll发布了新的文献求助10
34秒前
苗条丹南完成签到 ,获得积分10
34秒前
hnu发布了新的文献求助10
36秒前
36秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989957
求助须知:如何正确求助?哪些是违规求助? 3532034
关于积分的说明 11256000
捐赠科研通 3270880
什么是DOI,文献DOI怎么找? 1805070
邀请新用户注册赠送积分活动 882252
科研通“疑难数据库(出版商)”最低求助积分说明 809216